Company Overview
Scientific Advisory Board
- SHAUN COUGHLIN, M.D., Ph.D.
Director, Cardiovascular Research Institute, University of California San Francisco
Director, Daiichi Research Center, University of California San Francisco - CHARLES ESMON, Ph.D.
Head of the Coagulation Biology Laboratory at the Oklahoma Medical Research Foundation - ARTHUR WEISS, M.D., Ph.D.
Chief, Rheumatology, University of California San Francisco
Director, Medical Scientist Training Program, University of California San Francisco
SHAUN COUGHLIN, M.D., Ph.D.
Director, Cardiovascular Research Institute, University of California San Francisco
Director, Daiichi Research Center, University of California San Francisco
Dr. Shaun Coughlin is Director of the Cardiovascular Research Institute, Director of the Daiichi Research Center and a Distinguished Professor of Cardiovascular Biology and Medicine, all programs which stem from the University of California, San Francisco. Dr. Coughlin’s marked accomplishments include his election into the National Academy of Sciences and numerous awards presented by the American Heart Association, including the Basic Science Prize and the Hoeg Award.
Back to top
CHARLES ESMON, Ph.D.
Head of the Coagulation Biology Laboratory at the Oklahoma Medical Research Foundation
Dr. Charles Esmon is a member of the National Academy of Sciences, an investigator at the Howard Hughes Medical Institute, and Head of the Coagulation Biology Laboratory at the Oklahoma Medical Research Foundation. He has more than 300 publications related to blood coagulation and inflammation areas and has served as a consultant with a number of large and small pharmaceutical companies. Among his contributions in the coagulation area were the identification of thrombomodulin (with Dr. Whyte Owen) and endothelial protein C receptor (with Dr. Kenji Fukudome). In the field of sepsis, he and Dr. Fletcher Taylor were the first to show that activated protein C could prevent and treat septic animals challenged with normally lethal levels of bacteria. Most recently, he has shown that cell death can trigger multi-organ failure by releasing DNA/histone complexes that cause multi-organ failure, a process that can be blocked by inhibiting the toxic histones.
Back to top
ARTHUR WEISS M.D., Ph.D.
Chief, Rheumatology, University of California San Francisco
Director, Medical Scientist Training Program, University of California San Francisco
Dr. Arthur Weiss is Chief of the Division of Rheumatology and Director of the Medical Scientist Training Program, both at the University of California San Francisco. Dr. Weiss was also named an Ephraim P. Engleman Distinguished Professor and is also a member of the U.S National Academy of Sciences, Institute of Medicine and the American Academy of Arts and Sciences.